162 related articles for article (PubMed ID: 36658117)
21. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
[TBL] [Abstract][Full Text] [Related]
22. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
[TBL] [Abstract][Full Text] [Related]
23. miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma.
Qu D; Yang Y; Huang X
J Cell Biochem; 2019 Aug; 120(8):13562-13572. PubMed ID: 30937952
[TBL] [Abstract][Full Text] [Related]
24. Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.
Feng S; Zhang L; Liu X; Li G; Zhang B; Wang Z; Zhang H; Ma H
J Cell Mol Med; 2020 Jul; 24(14):7789-7801. PubMed ID: 32519437
[TBL] [Abstract][Full Text] [Related]
25. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.
Chen K; Qian W; Li J; Jiang Z; Cheng L; Yan B; Cao J; Sun L; Zhou C; Lei M; Duan W; Ma J; Ma Q; Ma Z
Mol Oncol; 2017 Oct; 11(10):1475-1492. PubMed ID: 28783244
[TBL] [Abstract][Full Text] [Related]
26. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
27. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
28. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
29. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
Huang W; Zhu S; Liu Q; Li C; Li L
Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
[TBL] [Abstract][Full Text] [Related]
30. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS
Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361
[TBL] [Abstract][Full Text] [Related]
31. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
32. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
33. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.
Kim HS; Kim MJ; Kim EJ; Yang Y; Lee MS; Lim JS
Biochem Pharmacol; 2012 Feb; 83(3):385-94. PubMed ID: 22120676
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
[TBL] [Abstract][Full Text] [Related]
35. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
38. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
[TBL] [Abstract][Full Text] [Related]
39. Isoflurane activates AMP-activated protein kinase to inhibit proliferation, and promote apoptosis and autophagy in cervical carcinoma both
Wei H; Sun T; Liu J; Wang X; Zhao G; Shi J; Chen Y
J Recept Signal Transduct Res; 2021 Dec; 41(6):538-545. PubMed ID: 33043765
[TBL] [Abstract][Full Text] [Related]
40. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells.
Chu SC; Yu CC; Hsu LS; Chen KS; Su MY; Chen PN
Mol Pharmacol; 2014 Dec; 86(6):609-23. PubMed ID: 25217495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
